• D. Boral Capital Reiterates "Buy" Rating for ImmunityBio (NASDAQ:IBRX)

    المصدر: Buzz FX / 20 ديسمبر 2024 09:56:14   America/Chicago


    D. Boral Capital Reiterates "Buy" Rating for ImmunityBio (NASDAQ:IBRX) Written by MarketBeat December 20, 2024 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating restated by equities
    Read more...
شارك على،